SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-15-046591
Filing Date
2015-08-05
Accepted
2015-08-05 17:14:55
Documents
11
Period of Report
2015-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v416176_10q.htm 10-Q 336512
2 EXHIBIT 31.1 v416176_ex31-1.htm EX-31.1 9612
3 EXHIBIT 31.2 v416176_ex31-2.htm EX-31.2 9648
4 EXHIBIT 32.1 v416176_ex32-1.htm EX-32.1 4923
5 EXHIBIT 32.2 v416176_ex32-2.htm EX-32.2 5223
  Complete submission text file 0001144204-15-046591.txt   3404989

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pip-20150630.xml EX-101.INS 511311
7 XBRL TAXONOMY EXTENSION SCHEMA pip-20150630.xsd EX-101.SCH 40794
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pip-20150630_cal.xml EX-101.CAL 51749
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pip-20150630_def.xml EX-101.DEF 161316
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pip-20150630_lab.xml EX-101.LAB 693296
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pip-20150630_pre.xml EX-101.PRE 293363
Mailing Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401
Business Address ONE PARK PLACE, SUITE 450 ANNAPOLIS MD 21401 410 269 2600
PHARMATHENE, INC (Filer) CIK: 0001326190 (see all company filings)

IRS No.: 202726770 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-32587 | Film No.: 151029944
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences